Up substantially from 01/01, stock has hit a pot hole as this simple chart shows. The explanations will vary depending on whom you ask. MC is small $20mil. SK is only an 11-month old company. Once SK shows that cash sales of its numerous licensed products -- incl. Yak and Yeti lines; others new and revolutionary like Dharmanol and later T-Hydrocan -- are reducing accounts receivables owed to SK, it's off to the races. Dharmanol is potential blockbuster and news maker; the collectives are just in past week receiving shipments.  Monarch vapes appear to be hot seller. There are now over 400 dispensaries throughout CA that sell licensed SK products. It's thought that Q4 2013 and Q1 2014 will show substantial growth in cash sales.